Anthony Oro MD/PhD
Academic Appointments
- Professor, Dermatology
- Member, Bio-X
- Member, Child Health Research Institute
- Member, Stanford Cancer Institute
Key Documents
Contact Information
-
Clinical Offices
Adult Dermatology Clinic 450 Broadway Street, Pavilion B MC 5334 Redwood City, CA 94063 Tel Work (650) 723-6316 Fax (650) 721-3476
- Academic Offices
Personal Information Email Tel (650) 725-7022Alternate Contact Ray Herrman administrative assistant Email Tel Work 650-725-7022Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Dermatology
- Skin Cancer
- Hair disorders
Professional Education
| Board Certification: | Dermatology, American Board of Dermatology (1998) |
| Residency: | Stanford University Medical Center CA (1997) |
| Internship: | Stanford University Medical Center CA (1994) |
| Medical Education: | UCSD School of Medicine CA (1993) |
Postdoctoral Advisees
Scott Atwood, Susie Lee, Lingjie Li, Sandra Melo Carlos, Gozde Yucel
Graduate & Fellowship Program Affiliations
Internet Links
Scientific Focus
Current Research Interests
Our lab is interested in the role of Sonic hedgehog (Shh) signaling system in the pathogenesis of the most common human tumor, basal cell carcinoma (BCCs) of the skin. Induction of Shh target genes mediate normal hair follicle morphogenesis. However, ectopic Shh target gene induction result in BCC tumor development from normal skin. We are interested in
1)how tumor stroma regulates Shh signaling and BCC progression
2) identifying Shh target genes that mediate the dramatic histologic changes in epithelium. We are using transgenic and knockout mice, retroviral infections in primary human and mouse cells, and DNA microarrays to address this questions. Our ultimate goal is to understand the pathogenesis of epithelial cancer in order to develop novel anti-tumor therapeutics.
Most recently we have identified a Shh target gene called MIM that is an inducible actin cytoskeleton remodeling protein. MIM binds to the tumor suppressor Suppressor of Fused and the oncogene Gli to potentiate Gli transcription.
Clinical Trials
- A Phase II Study of Efficacy and Safety in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma (BOLT) Recruiting
- A Study of GDC-0449 (Hedgehog Pathway Inhibitor) in Patients Treated With GDC-0449 in a Previous Genentech-Sponsored Phase I or II Cancer Study Recruiting
- Pilot LDE225 in Locally Advanced or Metastatic BCC + Previously Tx Non-LDE225 Smoothened Inhibitors Recruiting
- Characteristics of Patients with Dystrophic Epidermolysis Bullosa Recruiting
- A Study of GDC-0449 in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma No longer recruiting
Publications
- Cell migration: GSK3β steers the cytoskeleton's tip. Cell. 2011; (3): 319-21
- In vivo imaging of human and mouse skin with a handheld dual-axis confocal fluorescence microscope. J Invest Dermatol. 2011; (5): 1061-6
- SnapShot: hair follicle stem cells. Cell. 2011; (2): 334-334.e2
- Top-accessed article: Basal cell nevus syndrome. Arch Dermatol. 2011; (10): 1213
- BAR domain competition during directional cellular migration. Cell Cycle. 2010; (13): 2522-8

